Brief: Mankind Pharma Q3 Consol Net Profit 4.09 Billion Rupees
03/02/2026 10:46
Feb 3 (Reuters) - Mankind Pharma Ltd MNKI.NS: MANKIND PHARMA Q3 CONSOL NET PROFIT 4.09 BILLION RUPEES MANKIND PHARMA Q3 CONSOL REVENUE FROM OPERATIONS 35.67 BILLION RUPEES Source text: [ID:] Further company coverage: MNKI.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery